ClinicalTrials.govpublic full text
Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer
triple negative breast cancer, tivozanib hydrochloride, paclitaxel, pharmacokinetics, biomarkers, metastatic breast cancer, mbc, tnbc, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 871400
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.